Acadian Asset Management LLC Sorrento Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 30, 2018
SELL
$4.22 - $7.5 $126,156 - $224,212
-29,895 Closed
0 $0
Q2 2018

Jul 24, 2018
SELL
$4.75 - $8.0 $423,362 - $713,032
-89,129 Reduced 74.88%
29,895 $215,000
Q1 2018

Apr 12, 2018
BUY
$4.5 - $9.95 $298,048 - $659,018
66,233 Added 125.46%
119,024 $613,000
Q4 2017

Jan 18, 2018
BUY
$1.75 - $3.8 $92,384 - $200,605
52,791
52,791 $200,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email